2nd Quarter - Report
BRAVO GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Firm
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Biopharmaceutical issues including: social and economic value of the biopharmaceutical sector, patient access and safety issues, life science innovation and job impact.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS BRAVACOS | — |
| JENNIFER LAURA RILEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.